Concepedia

Sreedhar Katragadda

SK

Statistics

Publications

3

Citations

134

H-Index

3

Active since

2009

Affiliations

University of Chicago(Current)

Dana-Farber Cancer Institute

Alliance Data (United States)

Harvard University

Duke University

Sreedhar Katragadda is an author at University of Chicago specializing in oncology, medicine, and chemotherapy.

Publications per year

2009–2021

3

Publications

3

Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)

Jonathan E. Rosenberg, Susan Halabi, Amir Mortazavi et al. · Journal of Clinical Oncology · 2021 · 57 citations · Full text

Medicine, Oncology, Urology +14

A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

Rogério Lilenbaum, Michael A. Samuels, Xiaofei Wang et al. · Journal of Thoracic Oncology · 2014 · 55 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Temozolomide and cisplatin in relapsed/refractory acute leukemia

Karen Seiter, Sreedhar Katragadda, Doris M. Ponce et al. · Journal of Hematology & Oncology · 2009 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

1–3 of 3